Sanofi India
BSE 500674
7 stories, newest first.
- Board meeting on 29 October 2026 to consider Q2 results and interim dividend
- Promoter group entity acquires 3,500,000 shares (15.20%) from a promoter in inter-se transfer
- GST Show Cause Notice of Rs.16,40,07,641 received for FY 2022-23
- Promoter group inter-se transfer: 35,00,000 shares (15.20%) move from Hoechst GmbH to Sanofi Healthcare India
- Promoter group entity buys 35,00,000 shares (15.20%) from Hoechst GmbH via block deal
- Promoter Hoechst GmbH transfers 35,00,000 shares to promoter group entity via block deal
- GST Show Cause Notice of Rs. 23,73,76,507 Received Over Alleged Excess Input Tax Credit for FY 2022-23
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.